BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MicroAire Surgical Instruments Acquires Endotine(R) (Formerly Owned by Coapt Systems, Inc.)


8/20/2010 9:43:15 AM

CHARLOTTESVILLE, Va., Aug. 19 /PRNewswire/ --MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to bone, or to other soft tissue -- using special tines instead of sutures -- thereby avoiding the tissue-strain associated with sutures.

Although Endotine® devices have the holding power of multiple sutures; the system actually has more in common with hook-and-loop systems, than with traditional needle and thread. This unique system allows surgeons to adjust the degree of lift during surgery. The additional strength from Endotine's® multiple fixation-points reduces tissue stretching and potential suture failure in a variety of facial procedures, including brow lifts, midface lifts, face lifts and neck lifts.

Endotine® is bioabsorbable, which means there are no secondary procedures required for implant removal. Endotine® devices hold tissue securely for three to four months and are then absorbed naturally, typically over a twelve-month period. With seven years of clinical history, including excellent success rates in peer-reviewed publications, clinical trials showed virtually no issues of inflammation or adverse histologic response.

Customers and distributors of Endotine® devices will see no change in the availability of the products. MicroAire is planning to continue the product, invest in the product and grow the brand.

"Many surgeons already know that this is a fantastic product," said Alan Connor, MicroAire's Vice President of Operations. "We're ensuring that manufacturing and distribution processes remain the same, so that customers and distributors have full access to Endotine® products, as they always have. Same people, same location, same contact information. The only change for now will be the addition of the MicroAire logo, and our commitment to supporting and growing this product line."

MicroAire will continue to use the Coapt name on product packaging and some business documents during the period of product registration and transfer to MicroAire.

MicroAire Surgical Instruments, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas: Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery. MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes. For more information, visit www.microaire.com.

Donald J. Crotteau

+1 434 975 8389

dj.crotteau@microaire.com



SOURCE MicroAire Surgical Instruments



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES